Administrative Supplement - A151804 irAE Biobanking

项目总结 该联盟是一个经验丰富的多机构癌症临床试验小组，已在 对国际移民组织协商一致报告和NCI关于合作小组重组的指示的回应。联盟提供 全面而高效的临床试验基础设施，可以接触到所有领域的经验丰富的合作者 肿瘤学临床试验研究的学科，以及针对乳房患者的各种试验组合， 胃肠道、泌尿生殖系统、呼吸系统、中枢神经系统、血液系统恶性肿瘤 罕见的肿瘤。该联盟的特别优势包括长期合作研究的传统 遗留成员，包括许多自#年成立以来一直参与合作小组研究的成员 1955年。 肿瘤学临床试验联盟的使命是通过以下方式减少癌症的影响： ·进行高质量的多学科癌症控制、预防和治疗试验， 综合研究网络； ·加深我们对癌症过程及其治疗的生物学基础的了解； 发现、验证、临床实践； ·为创新的临床和转化性研究提供科学和操作基础设施 学术和社区环境。

PROJECT SUMMARY The Alliance is an experienced multi-institutional cancer clinical trials group that has been reorganized in response to the IOM consensus report and NCI directives for cooperative group reorganization. Alliance provides a comprehensive and highly efficient clinical trials infrastructure, access to experienced collaborators across all disciplines of oncology clinical trials research, and a diverse portfolio of trials for patients with breast, gastrointestinal, genitourinary, respiratory, central nervous system, hematological malignancies, and selected rare tumors. Particular strengths of the Alliance include the long-standing tradition of collaborative research of the legacy members, including many who have participated in cooperative group research since its inception in 1955. The Mission of the Alliance for Clinical Trials in Oncology is to reduce the impact of cancer by: • Conducting high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network; • Furthering our understanding of the biological basis of the cancer process and its treatment; from discovery, to validation, to clinical practice; • Providing a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings.